s6y
Company name or ticker
Search
Klee Justin B.
3
Amylyx Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
Filed
Thursday, January 6, 2022
Period
Jan 6, 2022
Accession number
0000899243-22-001225
Documents
FORM 3 SUBMISSION
3
On sec.gov
Filing index
All files
Complete submission text
SGML header